Taro Pharmaceutical Industries Ltd

FRA:TAL (Israel)  
€ 38.60 (-1.03%) May 16
34.59
P/B:
0.89
Market Cap:
€ 1.46B ($ 1.58B)
Enterprise V:
€ 677.50M ($ 734.61M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Taro Pharmaceutical Industries Ltd ( FRA:TAL ) from 2014 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Taro Pharmaceutical Industries stock (FRA:TAL) PE ratio as of May 17 2024 is 34.59. More Details

Taro Pharmaceutical Industries Ltd (FRA:TAL) PE Ratio (TTM) Chart

To

Taro Pharmaceutical Industries Ltd (FRA:TAL) PE Ratio (TTM) Historical Data

Total 1238
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Taro Pharmaceutical Industries PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-17 34.2 2024-03-12 34.0
2024-05-16 34.2 2024-03-11 33.9
2024-05-15 34.6 2024-03-08 34.0
2024-05-14 34.6 2024-03-07 33.2
2024-05-13 34.6 2024-03-06 34.0
2024-05-10 34.8 2024-03-05 34.2
2024-05-09 34.8 2024-03-04 34.2
2024-05-08 34.9 2024-03-01 34.4
2024-05-07 34.9 2024-02-29 34.2
2024-05-06 34.8 2024-02-28 34.2
2024-05-03 34.9 2024-02-27 34.2
2024-05-02 34.9 2024-02-26 34.2
2024-04-30 34.9 2024-02-23 34.4
2024-04-29 34.9 2024-02-22 34.4
2024-04-26 35.1 2024-02-21 34.4
2024-04-25 34.6 2024-02-20 34.6
2024-04-24 34.9 2024-02-19 34.6
2024-04-23 35.1 2024-02-16 34.8
2024-04-22 34.9 2024-02-15 34.8
2024-04-19 34.9 2024-02-14 34.9
2024-04-18 34.9 2024-02-13 34.8
2024-04-17 34.9 2024-02-12 34.6
2024-04-16 34.9 2024-02-09 34.6
2024-04-15 34.9 2024-02-08 34.6
2024-04-12 34.8 2024-02-07 35.3
2024-04-11 34.6 2024-02-06 34.8
2024-04-10 34.4 2024-02-05 34.9
2024-04-09 34.0 2024-02-02 34.9
2024-04-08 34.2 2024-02-01 35.1
2024-04-05 34.4 2024-01-31 35.1
2024-04-04 34.4 2024-01-30 35.1
2024-04-03 34.6 2024-01-29 35.1
2024-04-02 34.8 2024-01-26 35.3
2024-03-28 34.4 2024-01-25 34.2
2024-03-27 34.4 2024-01-24 34.2
2024-03-26 34.4 2024-01-23 34.0
2024-03-25 34.2 2024-01-22 34.2
2024-03-22 34.4 2024-01-19 34.2
2024-03-21 34.2 2024-01-18 33.3
2024-03-20 34.2 2024-01-17 33.3
2024-03-19 34.0 2024-01-16 33.5
2024-03-18 34.2 2024-01-12 33.3
2024-03-15 34.2 2024-01-11 33.2
2024-03-14 34.0 2024-01-10 33.2
2024-03-13 33.9 2024-01-09 33.0

Taro Pharmaceutical Industries Ltd (FRA:TAL) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.